SarcopeniaNCT07724587
The Effectiveness and Safety of Combined Research on Uremic Sarcopenia
A study testing Received mindfulness meditation training during dialysis in addition to exercise therapy. in people with Sarcopenia, run by Ningbo Medical Center Lihuili Hospital at 1 site in China.
Trial summary
Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD). Read more about this study
- Who is it for?
- Ages 18 to 80 years
- Conditions the study is for
- Sarcopenia
- What is being tested?
- Received mindfulness meditation training during dialysis in addition to exercise therapy.
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 76 participants
- Where
- 1 siteChina
- Study dates
- 1 Sep 2025to 1 Dec 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 80 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Meet the updated Asian diagnostic criteria for sarcopenia
- Stable vital signs and general physical condition
- Willing and able to cooperate with supervised exercise training
- Regular hemodialysis 3 times per week for at least 3 months
Who cannot join
- Acute cardiovascular or cerebrovascular events within the previous 3 months
- Cognitive dysfunction affecting study cooperation and exercise completion
- Severe osteoarticular or limb movement disorders preventing standardized exercise training
- Active systemic infection
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
China1 site, 1 recruiting
- Recruiting
Yongyao Wu
Ningbo, 315100
yongyao wu, wuyongyao.12345@163.com
About this study
Official title: A Study on the Clinical Efficacy and Safety Evaluation of Mindfulness Meditation During Dialysis Combined With Pre-Dialysis Progressive Resistance Training for Hemodialysis Patients With Sarcopenia
Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD).
Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG). All groups received standard dialysis, health education, and dietary guidance. The SG received pre-dialysis PRT, while the IG added mindfulness meditation during dialysis. Efficacy and safety were evaluated at baseline and after 12 weeks. Ultrasound assessments of muscle mass were conducted at baseline, week 4, week 8, and week 12.
Read the detailed description
Control Group: Received routine hemodialysis treatment. Sports Group: Received pre-dialysis resistance training in addition to routine treatment.
Combined Intervention Group: Received mindfulness meditation training during dialysis in addition to exercise therapy.
The study was designed as a single-blind trial. The outcome assessors were blinded to group allocation to reduce assessment bias, particularly in the evaluation of subjective measures such as sleep quality, anxiety, and depression.
Interventions and Methods: Including 4 parts: Part 1 comprehensive assessment and preliminary education; Part 2 testing of one repetition maximum (1RM); Part 3 pre-dialysis resistance training; Part 4 mindfulness meditation training during dialysis.
Comprehensive Assessment and Preliminary Education: Collection of general information (including gender, age, dialysis age, primary disease, etc.). Health education, dietary guidance (calorie intake 30-35kj/kg/d; protein intake 1.0-1.2g/kg/d; maintain weight gain during dialysis within 3%-5% of dry weight). Establishment of a joint intervention team (including 2 meditation instructors, 1 rehabilitation therapist, 2 specialists, and 2 nurses). One week before the trial, patients were introduced to the theoretical knowledge, specific methods, and precautions of mindfulness meditation and PRT training. According to the "Expert Consensus on Exercise Rehabilitation for Chinese Adult Patients with Chronic Kidney Disease" , all participants had no serious complications or comorbidities and were all medium-low risk patients who could undergo incremental moderate-high intensity RT (1 RM 70-85% exercise load).
1RM Assessment: First, perform 5-10 minutes of warm-up exercises for the relevant muscle groups. Choose a weight close to the individual's maximum effort to overcome and begin testing, requiring the completion of 2 squatting movements. Gradually increase the barbell weight in the order of 5kg, 2kg, and 1kg until only one squat can be completed. This weight is recorded as 1RM. Rest for 2-3 minutes between each squat attempt.
Resistance Training: Patients underwent resistance training in the hemodialysis center's gym under the guidance of a rehabilitation therapist 1-2 hours before each dialysis session. The RT prescription was formulated with reference to "the American College of Sports Medicine, ACSM Guidelines for Exercise Testing and Prescription (9th Edition)" and the 2020 KDIGO Clinical Practice Guidelines to develop individualized exercise programs . The control group received routine dialysis treatment.
Mindfulness Meditation Training: After starting dialysis and once blood pressure and heart rate stabilized (approximately 10 minutes), MHD patients were intervened upon using mindfulness hemodialysis meditation audio developed by Lihuili Hospital [20].
Observation Indicators and Methods:
Exercise Capacity: CS-30, HGS, 6MWT, 22StairsUpDownTime, TT10SU. The 30-second chair stand test was used to assess lower limb muscle strength in the "sit-to-stand" state before and after 12 weeks of intervention. Patients crossed their arms over their chest and then performed rapid, continuous "stand up, sit down" movements for a limited time of 30 seconds. The fewer the number of movements within 30 seconds, the worse the lower limb muscle strength. HGS: Measured 3 times using a T.K.K 5001GRIP-A grip strength meter (HKBG., Ltd, Sweden), and the average value was taken. 6MWT, time to climb up and down 22 stairs, and time to stand up and sit down 10 times were measured before and after 12 weeks of intervention. 6MWT: Performed according to the method reported by A.T.S . Subjects walked back and forth in a quiet and ventilated dialysis room corridor with a length of 30m, and the final 6MWT was measured. Time to climb up and down 22 stairs: Subjects continuously climbed up and down 22 stairs (vertical height of approximately 3.3m) and the time taken was recorded. Time to stand up and sit down 10 times: Subjects repeatedly stood up and sat down from a standard-height chair, and the time taken to stand up and sit down 10 times was recorded, and the average value was taken.
Dynamic Balance Function (Timed Up and Go Test, TUGT): The "stand-up and walk" test was used. After the "start" command was issued, the subject stood up from a seated position (on a chair with a backrest), then walked forward 3m as quickly as possible, then turned 180° around the 3m marker and quickly walked back to the chair and sat down with their back against the backrest. The time taken for the entire process was recorded. The longer the time taken, the worse the patient's dynamic balance function .
Ultrasound Examination of the Quadriceps Femoris : The patient was placed in a supine position with the upper body elevated 30°, and both legs were kept relaxed and straight while avoiding internal and external rotation of the hip and knee joints. The linear array probe was placed vertically at approximately the lower 1/3 of the line connecting the anterior superior iliac spine and the upper edge of the patella, keeping the sound beam perpendicular to the femoral body and the probe pointing dorsally. The probe position was adjusted to examine each muscle of the quadriceps femoris (including the cross-sectional area of the rectus femoris, the thickness of the rectus femoris, and the thickness of the vastus intermedius) on the right thigh. The values of each parameter of the quadriceps femoris on the right thigh were measured three times at W0, W4, W8, and W12, and the average value was taken.
5.4 Sleep, Anxiety, and Depression Scores: The Pittsburgh Sleep Quality Index (PSQI) , Self-Rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS) were used for evaluation .
The psychometric properties (validity and reliability) of these scales have been validated in populations similar to the study cohort, as referenced in previous literature. Assessors were trained and underwent consistency checks to ensure reliable application of these scales.
Laboratory Tests (Inflammatory Markers, Nutritional Markers, and Dialysis Adequacy): Fasting elbow venous blood was collected to measure interleukin-6 (IL-6), high-sensitivity C-reactive protein (Hs-CRP), tumor necrosis factor (TNF), albumin (ALB), prealbumin (PA), adequacy index (KT/V), etc., before and after the intervention.
Comparison of the occurrence of adverse reactions: Adverse events were monitored throughout the study. These included physical injuries from exercise, as well as psychological distress related to the mindfulness meditation intervention. Adverse events were classified according to their severity and managed appropriately. A report and monitoring mechanism was established for any serious adverse events.
- Conditions
- Sarcopenia
- Being tested
- Received mindfulness meditation training during dialysis in addition to exercise therapy.
- Medical subject headings
- Sarcopenia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Received mindfulness meditation training during dialysis in addition to exercise therapy.Behavioural
The SG received pre-dialysis progressive resistance training (PRT), while the IG added mindfulness meditation during dialysis.
| Study group | Role | What they receive |
|---|---|---|
| control group (CG) | Other | Received routine hemodialysis treatment Receives: Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy. |
| sports group (SG) | Active comparator | Received pre-dialysis resistance training in addition to routine treatment. Receives: Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy. |
| intervention group (IG) | Experimental | Received mindfulness meditation training during dialysis in addition to exercise therapy. Receives: Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in 30-second Chair Stand Test (CS30)
The range of the test result is 0-30 repetitions. Higher values indicate better lower limb muscle strength and physical function. The change value before and after 12-week intervention is the evaluation index
Measured: 12 weeks
Change in Handgrip Strength
The unit of handgrip strength is kg. Higher values indicate improved upper limb muscle strength. The change value before and after 12-week intervention is the evaluation index
Measured: 12 weeks
Change in 6-Minute Walking Test (6MWT)
The unit of walking distance is meters. Longer walking distance indicates better exercise tolerance and physical endurance. The change value before and after 12-week intervention is the evaluation index.
Measured: 12 weeks
Change in Stair Climbing Test
The unit of test result is seconds. Shorter completion time indicates improved lower limb motor function. The change value before and after 12-week intervention is the evaluation index.
Measured: 12 weeks
Change in 10-Time Sit-to-Stand Test (TT10SU)
The unit of test result is seconds. Shorter completion time indicates better lower limb muscle function. The change value before and after 12-week intervention is the evaluation index.
Measured: 12 weeks
Change in Timed Up and Go Test (TUGT)
The unit of test result is seconds. Shorter completion time indicates better balance and mobility function. The change value before and after 12-week intervention is the evaluation index.
Measured: 12 weeks
Change in skeletal muscle thickness measured by ultrasound
The unit of skeletal muscle thickness is cm. Greater muscle thickness indicates improved muscle mass. The change value before and after 12-week intervention is the evaluation index.
Measured: 4 weeks
Change in quality of life assessed by standardized scale
Higher scores of the standardized quality of life scale represent improved quality of life and physical performance. The change value before and after 12-week intervention is the evaluation index.
Measured: 12 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Jul 2026
- Study start1 Sep 2025
- Primary completion1 Dec 2026 (estimated)
- Study completion1 Dec 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for SarcopeniaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 76 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Ningbo Medical Center Lihuili Hospital
- Sponsor type
- Other government
- Responsible party
- Sponsor
- Investigators
- yongyao wu, Principal investigator, Department of Nephrology, Ningbo Medical Center Li Huili Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07724587
- Sponsor's protocol ID
- KY2025PJ 498
- Status last verified
- Sep 2025
- First submitted
- 22 Apr 2026
- Last updated
- 24 Jul 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 24 Jul 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Study on the Clinical Efficacy and Safety Evaluation of Mindfulness Meditation During Dialysis Combined With Pre-Dialysis Progressive Resistance Training for Hemodialysis Patients With Sarcopenia
- ClinicalTrials.gov ID
- NCT07724587
- Acronym / sponsor ID
- KY2025PJ 498
- Conditions
- Sarcopenia
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 76 participants (estimated)
- Lead sponsor
- Ningbo Medical Center Lihuili HospitalOther government
- Study start
- 1 Sep 2025 (actual)
- Primary completion
- 1 Dec 2026 (estimated)
- Study completion
- 1 Dec 2026 (estimated)
- First posted
- 24 Jul 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Objective: To investigate the clinical efficacy and safety of mindfulness meditation during dialysis combined with pre-dialysis progressive resistance training (PRT) for sarcopenia in patients undergoing maintenance hemodialysis (MHD).
Methods: In the randomized controlled trial, 76 MHD patients with sarcopenia were divided into three groups: control group (CG), sports group (SG), and intervention group (IG). All groups received standard dialysis, health education, and dietary guidance. The SG received pre-dialysis PRT, while the IG added mindfulness meditation during dialysis. Efficacy and safety were evaluated at baseline and after 12 weeks. Ultrasound assessments of muscle mass were conducted at baseline, week 4, week 8, and week 12.
Detailed description
Control Group: Received routine hemodialysis treatment. Sports Group: Received pre-dialysis resistance training in addition to routine treatment.
Combined Intervention Group: Received mindfulness meditation training during dialysis in addition to exercise therapy.
The study was designed as a single-blind trial. The outcome assessors were blinded to group allocation to reduce assessment bias, particularly in the evaluation of subjective measures such as sleep quality, anxiety, and depression.
Interventions and Methods: Including 4 parts: Part 1 comprehensive assessment and preliminary education; Part 2 testing of one repetition maximum (1RM); Part 3 pre-dialysis resistance training; Part 4 mindfulness meditation training during dialysis.
Comprehensive Assessment and Preliminary Education: Collection of general information (including gender, age, dialysis age, primary disease, etc.). Health education, dietary guidance (calorie intake 30-35kj/kg/d; protein intake 1.0-1.2g/kg/d; maintain weight gain during dialysis within 3%-5% of dry weight). Establishment of a joint intervention team (including 2 meditation instructors, 1 rehabilitation therapist, 2 specialists, and 2 nurses). One week before the trial, patients were introduced to the theoretical knowledge, specific methods, and precautions of mindfulness meditation and PRT training. According to the "Expert Consensus on Exercise Rehabilitation for Chinese Adult Patients with Chronic Kidney Disease" , all participants had no serious complications or comorbidities and were all medium-low risk patients who could undergo incremental moderate-high intensity RT (1 RM 70-85% exercise load).
1RM Assessment: First, perform 5-10 minutes of warm-up exercises for the relevant muscle groups. Choose a weight close to the individual's maximum effort to overcome and begin testing, requiring the completion of 2 squatting movements. Gradually increase the barbell weight in the order of 5kg, 2kg, and 1kg until only one squat can be completed. This weight is recorded as 1RM. Rest for 2-3 minutes between each squat attempt.
Resistance Training: Patients underwent resistance training in the hemodialysis center's gym under the guidance of a rehabilitation therapist 1-2 hours before each dialysis session. The RT prescription was formulated with reference to "the American College of Sports Medicine, ACSM Guidelines for Exercise Testing and Prescription (9th Edition)" and the 2020 KDIGO Clinical Practice Guidelines to develop individualized exercise programs . The control group received routine dialysis treatment.
Mindfulness Meditation Training: After starting dialysis and once blood pressure and heart rate stabilized (approximately 10 minutes), MHD patients were intervened upon using mindfulness hemodialysis meditation audio developed by Lihuili Hospital [20].
Observation Indicators and Methods:
Exercise Capacity: CS-30, HGS, 6MWT, 22StairsUpDownTime, TT10SU. The 30-second chair stand test was used to assess lower limb muscle strength in the "sit-to-stand" state before and after 12 weeks of intervention. Patients crossed their arms over their chest and then performed rapid, continuous "stand up, sit down" movements for a limited time of 30 seconds. The fewer the number of movements within 30 seconds, the worse the lower limb muscle strength. HGS: Measured 3 times using a T.K.K 5001GRIP-A grip strength meter (HKBG., Ltd, Sweden), and the average value was taken. 6MWT, time to climb up and down 22 stairs, and time to stand up and sit down 10 times were measured before and after 12 weeks of intervention. 6MWT: Performed according to the method reported by A.T.S . Subjects walked back and forth in a quiet and ventilated dialysis room corridor with a length of 30m, and the final 6MWT was measured. Time to climb up and down 22 stairs: Subjects continuously climbed up and down 22 stairs (vertical height of approximately 3.3m) and the time taken was recorded. Time to stand up and sit down 10 times: Subjects repeatedly stood up and sat down from a standard-height chair, and the time taken to stand up and sit down 10 times was recorded, and the average value was taken.
Dynamic Balance Function (Timed Up and Go Test, TUGT): The "stand-up and walk" test was used. After the "start" command was issued, the subject stood up from a seated position (on a chair with a backrest), then walked forward 3m as quickly as possible, then turned 180° around the 3m marker and quickly walked back to the chair and sat down with their back against the backrest. The time taken for the entire process was recorded. The longer the time taken, the worse the patient's dynamic balance function .
Ultrasound Examination of the Quadriceps Femoris : The patient was placed in a supine position with the upper body elevated 30°, and both legs were kept relaxed and straight while avoiding internal and external rotation of the hip and knee joints. The linear array probe was placed vertically at approximately the lower 1/3 of the line connecting the anterior superior iliac spine and the upper edge of the patella, keeping the sound beam perpendicular to the femoral body and the probe pointing dorsally. The probe position was adjusted to examine each muscle of the quadriceps femoris (including the cross-sectional area of the rectus femoris, the thickness of the rectus femoris, and the thickness of the vastus intermedius) on the right thigh. The values of each parameter of the quadriceps femoris on the right thigh were measured three times at W0, W4, W8, and W12, and the average value was taken.
5.4 Sleep, Anxiety, and Depression Scores: The Pittsburgh Sleep Quality Index (PSQI) , Self-Rating Anxiety Scale (SAS), and Self-Rating Depression Scale (SDS) were used for evaluation .
The psychometric properties (validity and reliability) of these scales have been validated in populations similar to the study cohort, as referenced in previous literature. Assessors were trained and underwent consistency checks to ensure reliable application of these scales.
Laboratory Tests (Inflammatory Markers, Nutritional Markers, and Dialysis Adequacy): Fasting elbow venous blood was collected to measure interleukin-6 (IL-6), high-sensitivity C-reactive protein (Hs-CRP), tumor necrosis factor (TNF), albumin (ALB), prealbumin (PA), adequacy index (KT/V), etc., before and after the intervention.
Comparison of the occurrence of adverse reactions: Adverse events were monitored throughout the study. These included physical injuries from exercise, as well as psychological distress related to the mindfulness meditation intervention. Adverse events were classified according to their severity and managed appropriately. A report and monitoring mechanism was established for any serious adverse events.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| control group (CG) | Other | Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.Received routine hemodialysis treatment |
| sports group (SG) | Active comparator | Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.Received pre-dialysis resistance training in addition to routine treatment. |
| intervention group (IG) | Experimental | Behavioral: Received mindfulness meditation training during dialysis in addition to exercise therapy.Received mindfulness meditation training during dialysis in addition to exercise therapy. |
Who may qualify
- Ages
- 18 to 80 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Meet the updated Asian diagnostic criteria for sarcopenia
- Stable vital signs and general physical condition
- Willing and able to cooperate with supervised exercise training
- Regular hemodialysis 3 times per week for at least 3 months
Key exclusion criteria (4 listed)
- Acute cardiovascular or cerebrovascular events within the previous 3 months
- Cognitive dysfunction affecting study cooperation and exercise completion
- Severe osteoarticular or limb movement disorders preventing standardized exercise training
- Active systemic infection
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Received mindfulness meditation training during dialysis in addition to exercise therapy.The SG received pre-dialysis progressive resistance training (PRT), while the IG added mindfulness meditation during dialysis. | Behavioural | control group (CG), intervention group (IG), sports group (SG) |
Primary outcome
Change in 30-second Chair Stand Test (CS30)
Time frame: 12 weeks
The range of the test result is 0-30 repetitions. Higher values indicate better lower limb muscle strength and physical function. The change value before and after 12-week intervention is the evaluation index
Change in Handgrip Strength
Time frame: 12 weeks
The unit of handgrip strength is kg. Higher values indicate improved upper limb muscle strength. The change value before and after 12-week intervention is the evaluation index
Change in 6-Minute Walking Test (6MWT)
Time frame: 12 weeks
The unit of walking distance is meters. Longer walking distance indicates better exercise tolerance and physical endurance. The change value before and after 12-week intervention is the evaluation index.
Change in Stair Climbing Test
Time frame: 12 weeks
The unit of test result is seconds. Shorter completion time indicates improved lower limb motor function. The change value before and after 12-week intervention is the evaluation index.
Change in 10-Time Sit-to-Stand Test (TT10SU)
Time frame: 12 weeks
The unit of test result is seconds. Shorter completion time indicates better lower limb muscle function. The change value before and after 12-week intervention is the evaluation index.
Change in Timed Up and Go Test (TUGT)
Time frame: 12 weeks
The unit of test result is seconds. Shorter completion time indicates better balance and mobility function. The change value before and after 12-week intervention is the evaluation index.
Change in skeletal muscle thickness measured by ultrasound
Time frame: 4 weeks
The unit of skeletal muscle thickness is cm. Greater muscle thickness indicates improved muscle mass. The change value before and after 12-week intervention is the evaluation index.
Change in quality of life assessed by standardized scale
Time frame: 12 weeks
Higher scores of the standardized quality of life scale represent improved quality of life and physical performance. The change value before and after 12-week intervention is the evaluation index.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 24 Jul 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Sarcopenia
Enrolling by invitation
Online Exercise Program for Transplant Patients: A Pilot Study
Kidney Transplantation, Physical Function
Not yet recruitingPhase 2
A Study of Bimagrumab in Participants With HFpEF
Heart Failure, Diastolic, Diastolic Heart Failure
Not yet recruiting
The Aim of the Study is to Decipher the Alterations in Signalling Pathways of Skeletal Muscle Stem Cells (Satellite Cells (SCs)) in Individuals With COPD, as Well as to Examine the Effect of Exercise Training on SCs.
COPD (Chronic Obstructive Pulmonary Disease), Sarcopenia in Elderly
Not yet recruitingPhase 2
MF-300 for Treatment of Age-Related Sarcopenia
Sarcopenia in Elderly
Not yet recruitingObservational study
Validation of Uzbek SARC-F and IPAQ-SF Questionnaires in Adults With and Without Hypothyroidism
Hypothyroidism, Psychometrics
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
yongyao wu principal investigator
Department of Nephrology, Ningbo Medical Center Li Huili Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Received mindfulness meditation training during dialysis in addition to exercise therapy. in people with Sarcopenia, run by Ningbo Medical Center Lihuili Hospital at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 24 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact yongyao wu (8615967857855, wuyongyao.12345@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in 30-second Chair Stand Test (CS30) (time frame: 12 weeks). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2026.